Pharmacists in Zion Crossroads, VA Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Dr. Danielle Danzi, PHARMD Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 82 Eagle Creek Ter, Zion Crossroads, VA 22942 Phone: 540-273-0068 |
Mrs. Theresa Simmons, RPH, BCACP Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 1015 Spring Creek Pkwy, Zion Crossroads, VA 22942 Phone: 434-243-9136 Fax: 434-243-9139 |
Trisha Marie Reddy, PHARM D Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 1015 Spring Creek Pkwy, Zion Crossroads, VA 22942 Phone: 434-243-9136 Fax: 434-243-9139 |
Alexis Park Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 164 Camp Creek Pkwy, Zion Crossroads, VA 22942 Phone: -- |
News Archive
Propensity for obesity, diabetes may occur in utero
The adage "You are what you eat" should be rephrased to include "and so are your children," based on metabolic research pioneered by researchers at the University at Buffalo.
Internap Network Services completes SAS 70 Type II audit for its company-controlled data centers
Internap Network Services Corporation, a global provider of end-to-end Internet business solutions, today announced it has successfully completed the Statement on Auditing Standards No. 70 (SAS 70) Type II audit for its company-controlled data centers. This activity is part of a continued commitment by Internap to provide advanced services to IT professionals interested in facilities that have demonstrated capabilities against the highest standards for service delivery.
Scientists explore susceptibility of different animals to SARS-CoV-2 infection
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
Hospira signs licensing agreement to develop and market DURECT's POSIDUR
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company, today announced that the companies have entered into a licensing agreement to develop and market DURECT's POSIDUR (SABER-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials.
New quantum sensor promises better imaging and cancer monitoring
Researchers at the University of Waterloo's Institute for Quantum Computing (IQC) have developed a new quantum sensor that could mean a significant advancement in 3D imaging and monitoring for cancer patients.
› Verified 8 days ago